Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, First In Human Study of DS-1055a in Subjects With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors

NCT04419532 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04419532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04419532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, First In Human Study of DS-1055a in Subjects With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors
Lead sponsor
Daiichi Sankyo
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 9, 2020
Completion date
July 1, 2027
Enrollment
40 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, metastatic solid tumor, solid tumor